Valeant’s Bausch + Lomb teams up with IBM for cataract surgery app
IBM (NYSE: IBM) and Bausch + Lomb, a wholly owned subsidiary of Valeant (NYSE: VRX), have announced a partnership that will see the development of a first-of-its-kind iOS app that will assist surgeons who perform cataract surgery.
The app help surgeons streamline their workflow by delivering patient information and clinical insights as well as intraocular lens (IOL) options on a single, digital platform at the point of care.
Cataract extraction is a very common surgical procedure and involves the removal of the cloudy lens, which is replaced with an artificial lens, or IOL.
The new app from Bausch + Lomb will be designed to provide surgeons with access to information that patients have agreed to share, enabling surgeons to effectively plan for the procedure with the option of viewing the information on digital devices or display screens on walls in the operating room during surgery.
The health-related data will be hosted on IBM cloud platform, Bluemix, a cloud based environment with added layers of security. The MobileFirst for iOS TEAM, part of IBM Global Business Services, will design and develop this custom app while the hope is that, over time, the app will be optimised to collect data resulting in a cognitive app that applies machine-based learning and predictive analytics to deliver real-time insights to surgeons.
Andy Chang, senior VP at Bausch + Lomb, says: “By combining IBM’s advanced data management capabilities with Apple’s innovative app ecosystem and our clinical expertise, we are working to provide surgeons with a convenient, personalised tool that helps them better manage and access patient profiles digitally, and provide personalised IOL options.”
Mahmoud Nagshineh, general manager of Apple partnership at IBM, comments: “Bausch + Lomb has identified a significant need in the ophthalmic community and the new app we will create will equip ophthalmologists with the data they need at their fingertips to help them make better, more informed decisions for their patients.”
Charac, an NHS-integrated pharmacy app, has raised £1.2m in debt and equity financing from the …
US tech firm IBM has reported that it has identified attempts by unknown parties to …